--- title: "Evolution (OM:EVO) Valuation Check After Q1 2026 Earnings Reset Expectations" type: "News" locale: "en" url: "https://longbridge.com/en/news/284816698.md" description: "Evolution (OM:EVO) has gained investor attention following its Q1 2026 earnings report, which showed sales of €513.04 million and net income of €251.93 million. The stock has seen a 30-day return of 11.64% and a 90-day gain of 9.50%, contrasting with a 3-year total shareholder return of -47.01%. Currently trading at SEK640.60, it is considered undervalued compared to a fair value of SEK876.22. However, concerns about growth, costs, and regulatory scrutiny may impact future performance." datetime: "2026-04-30T17:55:47.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/284816698.md) - [en](https://longbridge.com/en/news/284816698.md) - [zh-HK](https://longbridge.com/zh-HK/news/284816698.md) --- # Evolution (OM:EVO) Valuation Check After Q1 2026 Earnings Reset Expectations ## Q1 2026 earnings set the tone Evolution (OM:EVO) has drawn fresh investor attention after releasing first quarter 2026 earnings, with sales of €513.04 million and net income of €251.93 million setting a new reference point for the stock. See our latest analysis for Evolution. Since the Q1 2026 results and the recent board appointment on 24 April, Evolution’s 30 day share price return of 11.64% and 90 day gain of 9.50% contrast with a 3 year total shareholder return of negative 47.01%. This suggests short term momentum building against a weaker long term outcome. If Q1 earnings have you rethinking where growth could come from next, this is a good moment to widen your search with 38 AI infrastructure stocks With Evolution trading at SEK640.60 alongside an intrinsic value estimate implying roughly a 54% discount, yet sitting only about 2% below the average analyst target, investors may question whether there is a buying opportunity or whether the market is already pricing in future growth. ## Most Popular Narrative: 26.9% Undervalued At a last close of SEK640.60 versus a fair value narrative of SEK876.22, Evolution is framed as materially undervalued, according to Investingwilly’s widely followed thesis. > _Despite its strong financial performance and market leadership, Evolution is currently trading at historically low valuation multiples, which presents an opportunity for value-oriented investors. The recent decline in the stock price can be linked to concerns about slowing growth, increased costs, and regulatory scrutiny in specific markets, such as the UK._ Read the complete narrative. Want to see what sits behind that valuation gap? The narrative leans heavily on margin strength, long run revenue compounding, and a future earnings multiple that assumes sustained cash generation. Curious which combination of growth and profitability needs to hold for SEK876.22 to stack up? The full breakdown sets out those moving parts in plain numbers. **Result: Fair Value of SEK876.22 (UNDERVALUED)** Have a read of the narrative in full and understand what's behind the forecasts. However, this thesis could be shaken if regulatory scrutiny in key markets tightens materially or if rising costs pressure margins and weaken that high value score. Find out about the key risks to this Evolution narrative. ## Next Steps Given the mixed mood in this article, it helps to look at the facts yourself and move quickly while sentiment is still shifting, starting with the 3 key rewards ## Looking for more investment ideas? If Evolution has sharpened your focus, now is the time to broaden your watchlist so you do not miss other opportunities that fit your style. - Target dependable cash flows by checking out companies screened as 1 dividend fortresses for income focused portfolios. - Hunt for potential upside by scanning screener containing 1 high quality undiscovered gems before the crowd turns its attention there. - Prioritise resilience by reviewing 1 resilient stocks with low risk scores and see which names match your comfort with volatility. _This article by Simply Wall St is general in nature. **We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.** It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned._ ### Related Stocks - [EVVTY.US](https://longbridge.com/en/quote/EVVTY.US.md) ## Related News & Research - [Evolution Shares Jump 10% Following Massive €2 Billion Buyback Plan](https://longbridge.com/en/news/286877854.md) - [Evolution (OM:EVO) Margin Decline To 51.5% Tests Bullish Valuation Narratives](https://longbridge.com/en/news/283942681.md) - [Major Insider Makes Bold Multi-Million Dollar Move on Outset Medical Stock](https://longbridge.com/en/news/286852634.md) - [Evotec SE Successfully Placed €116.1 Million Convertible Bonds | EVO Stock News](https://longbridge.com/en/news/286159301.md) - [Major Insider Makes Bold Move on Outset Medical Shares](https://longbridge.com/en/news/286191792.md)